Metoclopramid Terapia

Metoclopramide, the active ingredient in Metoclopramid Terapia, is a dopamine D2 receptor antagonist presented as an injectable solution for intramuscular and intravenous use. It is employed to treat nausea, vomiting and gastroparesis in adult patients. GNH USA supplies Metoclopramid Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage conditions related to nausea, vomiting and delayed gastric emptying. - Nausea and vomiting: reduces the frequency and severity of episodes. - Post‑operative nausea and vomiting: prevents symptoms after surgical procedures. - Gastroparesis: enhances gastric motility and improves stomach emptying.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy. - Fatigue: reduced energy levels. - Restlessness: inability to stay still. - Diarrhea: loose, frequent stools. - Headache: mild to moderate pain. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Extrapyramidal reactions: involuntary muscle movements. - Tardive dyskinesia: persistent involuntary facial movements. - Neuroleptic malignant syndrome: life‑threatening hyperthermia. - Depression: worsening mood or suicidal thoughts. - Seizures: convulsive episodes. - Anaphylaxis: severe allergic reaction.

Before initiating therapy, consider the following safety measures. - Renal and hepatic assessment: evaluate function to adjust dosing if needed. - Extrapyramidal monitoring: watch for involuntary movements, especially in high‑risk patients. - Depression screening: be cautious in individuals with a history of mood disorders. - Hypersensitivity check: avoid use in patients with known allergy to metoclopramide. - Elderly caution: start with the lowest effective dose and monitor closely. - Store at room temperature: keep in the original pack, protect from moisture and light.

Metoclopramide can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Antipsychotics: increased risk of extrapyramidal symptoms. - MAO inhibitors: potential for hypertensive crisis. - CNS depressants: enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors: may raise metoclopramide plasma levels. - Anticholinergics: could reduce gastrointestinal pro‑kinetic effect. - Opioids: additive effects on gastrointestinal motility and sedation.